WW International reported a decrease in revenues and subscribers for Q3 2024, with revenues at $192.9 million and a decline in total subscribers to 3.7 million. However, the company saw growth in clinical subscribers and an improvement in gross margin. The company is reiterating its full year fiscal 2024 guidance.
End of Period Subscribers decreased to 3.7 million.
Revenues reached $192.9 million.
Gross margin was 67.1%, with an adjusted gross margin of 69.1%.
Operating Loss was $39.0 million, while adjusted operating income was $35.7 million.
The Company is reiterating its following full year fiscal 2024 guidance:
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance